To examine the changes of bone mineral density and bone turnover markers after Bonviva treatment in osteoporotic patients
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
100
Showa Inan General Hospital
Komagane, Nagano, Japan
RECRUITINGChanges of bone mineral density
To examine the changes of bone mineral density for the purpose of the effectiveness of the drug
Time frame: every 4-6 months
Improvement of bone turnover markers
To examine the changes of bone turnover markers for the purpose of the effectiveness of the drug
Time frame: Every 3-6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.